Top-tier U.S. life sciences VCs discuss the consequences of the faltering U.S. economy on how they manage their portfolios, and how speculative bubbles in life science disciplines no longer drive VC investment. While there is an emphasis on conservatism and cost-saving, investors are still seeking to drive innovation. The panelists also draw important distinctions between public and private investor behavior.
MaRS - Building Canada’s next generation of global technology companies. marsdd.com